← All trials
NCT03915366
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2020
- Primary completion
- Jan 1, 2020
- Completion date
- Jan 31, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 624
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Universidad Complutense de MadridLead sponsor
- Katholieke Universiteit LeuvenCollaborator
- University of BordeauxCollaborator
- Wellcome TrustCollaborator
- Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
- Makerere UniversityCollaborator
- University of BarcelonaCollaborator
- Government of MozambiqueCollaborator
- University of ZimbabweCollaborator
- University Teaching Hospital, Lusaka, ZambiaCollaborator
- University of LincolnCollaborator
- PENTA FoundationCollaborator
- Fundación para la Investigación Biomédica del Hospital 12 de OctubreStudy chair
- Universidade Eduardo MondlaneCollaborator
- Centre Hospitalier CocodyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.